Market Research Logo

Viral Vector Manufacturing Market by Type (Retrovirus, Gammaretrovirus, AAV), Disease (Cancer, Infectious Disease, Genetic Disorders), Application (Gene Therapy, Vaccinology), End User (Biotech companies, Research Institutes) - Global Forecast to 2023

Viral Vector Manufacturing Market by Type (Retrovirus, Gammaretrovirus, AAV), Disease (Cancer, Infectious Disease, Genetic Disorders), Application (Gene Therapy, Vaccinology), End User (Biotech companies, Research Institutes) - Global Forecast to 2023

“The global viral vector manufacturing market is projected to grow at a CAGR of 20.0%.”
The viral vector manufacturing market is expected to reach USD 815.8 million by 2023 from an estimated USD 327.8 million in 2018, at a CAGR of 20.0%. The growth of this market is expected to be driven by rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, effectiveness of viral vectors in gene therapy delivery, and ongoing research into viral vector-based gene & cell therapies. On the other hand, the high cost of gene therapies and short shelf-life of viral vectors are likely to restrain the growth of this market to a certain extent.

“The genetic disorders segment is expected to grow at the highest rate during the forecast period”
By disease, the viral vector manufacturing market is segmented into cancer, genetic disorders, infectious diseases, and other diseases. During the forecast period, the genetic disorders segment is expected to grow at the highest CAGR owing to the accelerated research activities on various genetic disorders such as hemophilia A and B, sickle cell anemia, and Huntington’s disease.

“The pharmaceutical and biopharmaceutical companies to hold the largest share of the market”
Based on end user, the global viral vector manufacturing market is segmented into pharmaceutical and biopharmaceutical companies and research institutes. The pharmaceutical and biopharmaceutical companies segment is expected to hold the largest share of the market in 2018. The successful launch of viral vector gene therapies and a robust pipeline of such therapies are the key factors contributing to the growth of the pharmaceutical and biopharmaceutical companies segment during the forecast period.

“North America is expected to dominate the viral vector manufacturing market in 2018”
In 2018, North America is expected to account for the largest share of 64.8% of the global viral vector manufacturing market. Factors such as a large number of regenerative medicine companies (including gene and cell therapy companies), increasing research activities, rising prevalence of target diseases, and availability of funding are supporting the growth of the viral vector manufacturing market in North America.

Break of primary participants was as mentioned below:
• By Company Type - Tier 1-40%, Tier 2-30% and Tier 3-30%
• By Designation - C-level-20%, Director Level-40%, Others-40%
• By Region - North America-50%, Europe-20%, Asia Pacific-20%, RoW-10%

The major players in the global viral vector manufacturing market are Lonza (Switzerland), Merck (Germany), Oxford BioMedica (UK), CGT Catapult (UK), Cobra Biologics (UK), uniQure (Netherlands), FUJIFILM Diosynth Biotechnologies (US), and Spark Therapeutics (US).

Research Coverage:
The report analyzes the viral vector manufacturing market and aims at estimating the market size and future growth potential of this market based on various aspects such as type, disease, application, end user, and region. The report also includes the competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by key players in the global viral vector manufacturing market. The report analyzes the global viral vector manufacturing market by type, disease, application, end user, and region
• Product Innovation: Detailed insights on upcoming trends and product launches in the global viral vector manufacturing market
• Market Development: Comprehensive information about the lucrative emerging markets by type, disease, application, and end user
• Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the market
• Competitive Assessment: In-depth assessment of market shares and growth strategies of leading players in the global market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
      • KEY INDUSTRY INSIGHTS
    • SECONDARY DATA
      • KEY DATA FROM SECONDARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • VIRAL VECTOR MANUFACTURING: MARKET OVERVIEW
    • EUROPE: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE AND COUNTRY (2018)
  • MARKET OVERVIEW
    • INTRODUCTION
    • EVOLUTION
      • Table APPROVED VIRAL VECTOR GENE THERAPIES
    • MARKET DYNAMICS
      • DRIVERS
        • Table NUMBER OF CLINICAL TRIALS REGISTERED ON VARIOUS VIRAL VECTORS GLOBALLY
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • VIRAL VECTOR MANUFACTURING MARKET, BY TYPE
    • INTRODUCTION
      • Table VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
    • RETROVIRAL VECTORS
      • LENTIVIRAL VECTORS
      • GAMMA-RETROVIRAL VECTORS
        • Table VIRAL VECTOR MANUFACTURING MARKET FOR RETROVIRAL VECTORS, BY REGION, 2016-2023 (USD MILLION)
        • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR RETROVIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
        • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR RETROVIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
    • ADENOVIRAL VECTORS
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR ADENOVIRAL VECTORS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR ADENOVIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR ADENOVIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
    • ADENO-ASSOCIATED VIRAL VECTORS
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR ADENO-ASSOCIATED VIRAL VECTORS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR ADENO-ASSOCIATED VIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR ADENO-ASSOCIATED VIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER VIRAL VECTORS
      • Table GENE THERAPY APPLICATIONS OF OTHER VIRAL VECTORS
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR OTHER VIRAL VECTORS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR OTHER VIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR OTHER VIRAL VECTORS, BY COUNTRY, 2016-2023 (USD MILLION)
  • VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE
    • INTRODUCTION
      • Table VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
    • CANCER
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR CANCER, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR CANCER, BY COUNTRY, 2016-2023 (USD MILLION)
    • GENETIC DISORDERS
      • Table PHASE III/IV CLINICAL TRIALS BASED ON MONOGENIC DISEASES
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR GENETIC DISORDERS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR GENETIC DISORDERS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR GENETIC DISORDERS, BY COUNTRY, 2016-2023 (USD MILLION)
    • INFECTIOUS DISEASES
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER DISEASES
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR OTHER DISEASES, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR OTHER DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR OTHER DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION
    • INTRODUCTION
      • Table VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
    • GENE THERAPY
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR GENE THERAPY, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR GENE THERAPY, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR GENE THERAPY, BY COUNTRY, 2016-2023 (USD MILLION)
    • VACCINOLOGY
      • Table VIRAL VECTOR VACCINES PIPELINE
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR VACCINOLOGY, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR VACCINOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR VACCINOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • VIRAL VECTOR MANUFACTURING MARKET, BY END USER
    • INTRODUCTION
      • Table VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
    • RESEARCH INSTITUTES
      • Table VIRAL VECTOR MANUFACTURING MARKET FOR RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • VIRAL VECTOR MANUFACTURING MARKET, BY REGION
    • INTRODUCTION
      • Table VIRAL VECTOR MANUFACTURING MARKET, BY REGION, 2016-2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • US
        • Table US: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table US: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
        • Table US: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table US: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • CANADA
        • Table CANADA: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CANADA: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
        • Table CANADA: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table CANADA: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table EUROPE: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • UK
        • Table UK: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table UK: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
        • Table UK: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table UK: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table GERMANY: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
        • Table GERMANY: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table GERMANY: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table FRANCE: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
        • Table FRANCE: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table FRANCE: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROE: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
        • Table ROE: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table ROE: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: VIRAL VECTOR MANUFACTURING MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: VIRAL VECTOR MANUFACTURING MARKET, BY DISEASE, 2016-2023 (USD MILLION)
      • Table ROW: VIRAL VECTOR MANUFACTURING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table ROW: VIRAL VECTOR MANUFACTURING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
      • Table RANK OF COMPANIES IN THE VIRAL VECTOR MANUFACTURING MARKET, 2017
      • COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2015-2018
      • PRODUCT APPROVALS
        • Table PRODUCT APPROVALS, 2015-2018
      • ACQUISITIONS AND MERGERS
        • Table ACQUISITIONS AND MERGERS, 2015-2018
      • EXPANSIONS
        • Table EXPANSIONS, 2015-2018
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2015-2018
  • COMPANY PROFILES
    • LONZA
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • OXFORD BIOMEDICA
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • CELL AND GENE THERAPY CATAPULT (CGT CATAPULT)
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SPARK THERAPEUTICS
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BRAMMER BIO
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • COBRA BIOLOGICS
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • FINVECTOR VISION THERAPIES
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
    • FUJIFILM HOLDINGS CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • KANEKA EUROGENTEC
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • MASSBIOLOGICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • NOVASEP
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • REGENXBIO
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • UNIQURE
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report